13.900
+8,59%
2026-09-23
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +51.3% | +71.2% | 2 / 3 | -24.8% | +5.49 pp | +0.76 pp | +1.2% | 0.13 | 83.63 | 38,2 | −24,8% | 0,4 | +144,8% | 83.63 | 32.54 | +157,0% |
| Pts | 8 | 12 | 8 | 0 | 12 | 8 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 13.900 (close price on 2026-09-23)EPS (TTM): 166,2
Financial charts
1.Revenue & growth
VND bn38,2Q2/26
1.Revenue & growth
VND bn38,2Q2/26
2.Profit & growth
VND bn-0,10Q2/26
3.Profit mix (Penman)
VND bn2,03Q2/26
4.Margins & cost structure
%15.1%Q2/26
5.Returns & cash cycle
% · days3.5%Q2/26
6.Earnings quality & cash
VND bn31,7Q2/26
7.Asset structure
VND bn130Q2/26
8.Funding & debt health
VND bn · times130Q2/26
9.Revenue backlog
VND bn3,17Q2/26
10.Valuation
times · %83,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-23Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26